Minocycline Foam: What Longer Follow-Up Shows

Zilxi is US-approved minocycline 1.5% foam for adults’ inflammatory rosacea lesions. It is applied once daily, not swallowed or used for infections.¹

Who continued?

The 40-week extension enrolled 504 adults who completed earlier 12-week trials without worsening: 332 previously received active foam, 172 foam without minocycline. Everyone then received active foam. Only 272 had at least a year’s active exposure.²

Ask your dermatologist which formulation is on the prescription. Our Emrosi comparison concerns an oral product and a different question.

What was measured?

There was no continuing control group. Of 504 entrants, 410 completed; week-52 efficacy observations covered 401. Among observed cases, 79.8% reached clear or almost-clear skin with a two-grade improvement from the original baseline. Missing outcomes were not estimated. Treatment could pause and restart; other rosacea medicines were allowed. Foamix sponsored the study; authors disclosed industry ties. These results cannot establish superiority over oral treatment or comparative long-term safety.²

Bring the study citation to your next review. Ask which findings describe remaining participants and which predict your treatment course. Write down the proposed review date and what would prompt an earlier appointment.

What belongs in your plan?

The US label contraindicates use with tetracycline or ingredient allergy. Discuss pregnancy and breastfeeding before treatment; breastfeeding is not recommended. The foam is flammable: avoid fire, flames and smoking during and immediately after application. Stop and seek prompt care for unusual headaches or vision changes; seek emergency care for breathing difficulty or facial swelling. Tell the prescriber about isotretinoin, anticoagulants and other medicines.¹

Bring photographs of every medicine and skin product you use, including treatments obtained elsewhere. Ask the pharmacist to confirm the exact product, local supply and storage instructions when filling the prescription.

The American Academy of Dermatology separates treatment for acne-like bumps from persistent color, visible vessels and eye symptoms. Gentle cleansing, moisturizer, sun protection and trigger management remain part of care, including maintenance.³

In Skin, Head to Toe, “Describe Your Own Face” explains how to record warmth, stinging and bumps alongside color. Take those notes to the appointment so the discussion covers the features that bother you.